Daily news email for May 30, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Zytoprotec Completes Phase I/II Trial of Novel Dialysate, Enters Into Negotiations with Global ...

ElexoPharm Receives 2.1 Million EUROSTARS Grant for Program Targeting Mitochondrial ...

Vetter Boosts Quality and Logistic Processes

Definiens Expands Functionality of Its Leading Solution for Quantitative Digital Pathology with ...

Antisense Pharma Internationalizes Management Board

BioSpace
Japanese-American Men With Low Vitamin-D Diet Face Higher Stroke Risk, University of Hawaii Study

No New Neurons in the Human Olfactory Bulb, Karolinska Institute Study

Babies Zero in on "Just Right" to Learn, University of Rochester Study

Seaweed Chemical Could be Key to Beat Arthritis University of California, San Diego (UCSD) Study

Anti-Psychotic Drug Pushes Cancer Stem Cells Over the Edge, McMaster University Study

BioSpace - Breaking News
Watson Pharmaceuticals, Inc. Confirms Testim Patent Challenge

Mylan Inc. Launches Generic Version of Bonviva Film Coated Tablets in the UK and Italy

Basilea Pharmaceutica Participates in Public-private Collaboration to Tackle Antibiotic Resistance

RegeneRx Biopharmaceuticals, Inc. Release: TB4 Provides Both Neuroprotection and Neurorestoration When Administered Shortly after Traumatic Brain Injury in Rat Model

Summit Corporation: Summit Announces Initiation of Phase 1 Trial for the Treatment of Duchenne Muscular Dystrophy

Biotech News - Business Wire
City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting Brain Tumor Stem Cells

BIO Applauds EPA's Rejection of a Petition to Retroactively Waive the 2011 Renewable Fuel Standard

Advanced Biological Laboratories' DeepChek® and ViroScore® Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic Use

MDxHealth : Assemblée Générale Ordinaire et Extraordinaire des actionnaires

MDxHealth: Annual and Extraordinary General Shareholders Meeting

Biotech News - PR Newswire
Nitor Group Demonstrates Direct Product Suite at Direct Implementation and Adoption Summit May 31-June 1

CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation

GenVec Reports Inducement Award

Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration

Marken Opens Branch Office In Seoul, South Korea

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
U.S. Could Lose its Competitive Edge in Biomedical Innovation

Homeland Security Warns of Mobile Health Risks

Death Rates among Americans with Diabetes Falls

PCORI Aims to Award $120 Million in 2012

NIH Study Shows Fake and Poor Quality Malaria Drugs Pose Threat

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

AspenBio Appoints Diagnostics Industry Veteran Don Hurd as Senior Vice President and Chief Commercial Officer

New Clinical Procedures, Practices and Interventions to Be Demonstrated at National Healthcare Event

Texas Researchers Studying Breast Cancer Prevention, Minorities and More Effective Treatments with $8.4 Million in New Research Funding from Susan G. Komen for the Cure®

Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012

Clinical Trials - PR Newswire
UCLA Launches First Face Transplantation Program In Western U.S.

PCA3 Test Featured at American Urological Association Meeting

UV-Blocking Contact Lenses May Have An Effect On Maintaining Eyes' Macular Pigment Density, Study Suggests

Allegheny General Hospital Hearing Specialists Introduce First-of-its-kind Therapy for Single-Sided Deafness and Conductive Hearing Loss

Uroplasty Announces Product Development and New Clinical Trial Initiatives

CNN Top Stories
Man arrested in Vatican documents leak

Widow of 9/11 pilot dies, friend says

Syrian opposition: Scores slaughtered

Opinion: Privacy is far from dead

Brush fire closes I-4 near Disney World

Contract Pharma
Onyx Scientific Appoints European BD Director

Takeda To Acquire Multilab

Clinilabs Opens New Phase I Unit

DSM Pharmaceutical Appoints President

Transgenomic Acquires Gene Logic Biorepository

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

FDA News - Business Wire
Cannabis Science Gets Set to Release Phytiva Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.

Fera Pharmaceuticals Preparing Resupply of Methazolamide Tablets

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer's Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)

Taro Provides Results for Three Months Ended March 2012

BIO Lauds Senate Passage of User Fee Package

FDA Press Releases
U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC

FDA-led research team discovers an autoimmune mechanism for serious drug-induced adverse reactions

FDA approves generic versions of blood thinner Plavix

FDA expands use for FilmArray Respiratory Panel

FDA issues alert on potential dangers of unproven treatment for multiple sclerosis

FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

FierceBiotech
See you after Memorial Day weekend

UPDATED: Sangart stashes $50M funding for oxygenation drugs

GSK gambles on biotech partners after dubious M&A deal

Vertex finds key support for cystic fibrosis drug in Europe

Elan boss: Climate improved for Alzheimer's drugs

FierceBiotech IT
Broken link found in electronic clinical trial startups

Pfizer brings Lipitor brand to mobile app stores

Relay launches 'Bloomberg' for biopharma dealmakers

Memorial Day break; Twitter chat reminder

Ex-Apple CEO forecasts tech-driven change in medicine

FierceBiotech Research
Mothers' breast milk may carry HIV fighting tool

Scientists morph skin cells from heart failure patients into healthy cardiac tissue

New strategy reactivates genes to suppress cancer

Malaria's genetic secrets open door to new drug targets

2 proteins appear crucial for aggressive cancer metamorphosis

FiercePharma
EMA supports Pradaxa but seeks sharper warnings for bleeding

House could vote on FDA bill next week

E.U. panel recommends Inlyta for adults with kidney cancer

While we are off for holiday weekend, cargo thieves are not

FDA relies on health professionals, not recall, with Hospira overfills

FiercePharma Manufacturing
Recipharm snags $114 million loan, says it's shopping

UPDATED: Marshals descend on Crescendo Therapeutics

Recipharm snags $114 million loan, says its shopping

Heart attack test alert from Alere

FDA takes aim at Spanish drugmaker

FierceVaccines
Flu shot cuts preterm births

Vitamin D boosts TB shot as cancer therapy

HIV vaccine carries its own adjuvant into clinical trials

Wishing you a happy HIV Vaccine Awareness Day

Vax-chemo combo offers some hope in pancreatic cancer

Health News - BizJournals.com
Baptist to proceed with emergency hospital in Schertz

PIP fraud draws 5.5-year sentence

Could New York cap hospital CEO pay

Bundled pay in Tennessee spotlight

Sutter opening Elk Grove surgery center

Health News - CNBC
California tobacco tax measure risks going up in smoke

Rite Aid appoints CEO as chairman of the board

Can kids be sent home right after appendectomy

Tranzyme GI drug fails second late-stage trial

Clock ticking on Illinois Medicaid, pension reforms

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Firefly Bags $500K from Massachusetts Life Science Center for miRNA Biomarker Platform

IMI Launches 223.7M Industry-Academia Program to Tackle Antibiotic Resistance

Nexavar Fails to Meet Primary Endpoint in Late-Stage NSCLC Study

France's Biotech Industry Faces Financing Challenge but Partnership Growth

Nexavar Fails to Meet Primary Endpoint in Phase III NSCLC Study

Marketwire - Pharma and Biotech
Oro Gold Cosmetics Wins Best Skin Care Line

Gemoscan Canada Announces Shares for Service Agreement

Synergetics USA to Participate in Two Upcoming Investor Conferences

Study Validating miRview mets2 Published in The Oncologist

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

MassBio News
MassBio Applauds Senators Kerry & Brown for Work on Passage of User Fee Package

MassBio Honored with NORD's Power of Partnership Award

10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

Medical Pharma - PR Newswire
UBM Canon and MD+DI Proudly Announce 25 Innovative Products as Winners of the 2012 Medical Design Excellence Awards

The Pancreatic Cancer Research & Education Act (S.362) Reaches 50 Senate Co-Sponsors and Majority of Senate Help Committee

Elanco's Consumer Advertising Campaign Raises Heartworm Awareness

Direct Relief Delivers Hurricane Packs As FEMA Urges Preparedness

Endo Health Solutions Inc. to Present at Jefferies 2012 Global Healthcare Conference

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

New York Times- Biotechnology
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

New York Times- Pharmaceuticals
Miralax, a Drug for Adults, Is Popular as a Children’s Remedy

Senate Backs Bill to Speed Drugs and Avert Shortages

Senate Passes Bipartisan Bill on New Medicines

F.D.A. Panel Votes Against Expansion of Anticoagulant

Fake and Substandard Drugs Grow as Threat to Fight Malaria

OnBioVC
S.E.A. Medical Systems, Inc.: Series B $3M

Phosphate Therapeutics, Ltd.: Series A $13.8M

CrystalGenomics, Inc.: Series A $2.6M

Heat Biologics, Inc.: Series A $2.8M

CN Creative, Ltd: Series A $3.1M

Outsourcing-Pharma
R&D and commercial work together to design trials, says DIA

Patheon launches CMC consultancy in face of restructuring plans

SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Pharmas must give patients voice says DIA Europe director

Pharma News - Business Wire
Quintiles nommée meilleur milieu de travail du Royaume-Uni

Quintiles wird als einer der besten Arbeitgeber in Großbritannien ausgezeichnet

InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 30th

Rite Aid Names John T. Standley Board Chairman

Samenvatting: Baxters lage glucose PD werkt positief bij diabetes patiënten

Pharma News - PharmiWeb
ICON Presents Successful Late Phase, Outcomes Research and Pricing Strategies at ISPOR 2012

BHI Raises Awareness of the Link Between Hearing Loss and Some Chronic Diseases During National Men's Health Week

Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board

American Council of the Blind Applauds U.S. Senate for Including Accessible Prescription Drug Labeling Legislation in User Fee Authorization

ONYX STRENGTHENS COMMERCIAL TEAM

Pharma News - PR Newswire
Albemarle to increase ibuprofen prices

K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity

Watson to Present at the Jefferies 2012 Global Healthcare Conference

Depomed To Present At Jefferies 2012 Global Health Care Conference

Delcath Prices $20 Million Public Offering of Common Stock and Warrants

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

PRWeb - Biotechnology
EnergyToolsInt.com Debuts New Web Design to Deliver Simplified Steps...

Cleaning in Green, MyCleaningProducts.com Releases Products that Clean...

Get Involved: the Salary Survey is Now Open for Life Science

Telcare's Wireless-Enabled Blood Glucose Monitoring System Wins...

EquipNet to Auction Off Entire Contents of Closed Merck Facility

PRWeb - Pharmaceuticals
REGISTRAT-MAPI Names Vice President, Clinical Operations EU

Franklin University Offers Enhanced Online Healthcare Information...

QHC Advisory Group, LLC, Adds Vice President, Business Development and...

Turmeric Found in Diabetes Support Supplements, a new product by...

Alcohol Rehab And Addiction Treatment Pioneer Dr. Mohammad Launches...

Scientific American
How Can We Cope with the Dirty Water from Fracking

Just How Big Was the Biggest Earthquake

Dollars and Scents: The Chemistry of a Delicious Tomato

Why America's Love Affair with Cars Is No Accident

"Artificial Leaf" Hits Development Hurdle

Sports - ESPN Basketball
Former UConn forward Smith transfers to UNLV

NCAA: Transfer Zeigler can join Pitt right away

Isiah Thomas eyes return to college or NBA

Man pleads guilty in San Diego gambling case

Rider associate Baggett elevated to head coach

Sports News - ESPN
Ex-Penn St. prez sues over Sandusky emails

Exonerated ex-USC recruit wants shot at NFL

AG: Sandusky dismissal premature sans 'facts'

Montana colleges OK new sexual assault policy

Montana regents OK new sexual assault policy

Xconomy Life Sciences
Michigan VC Report Highlights Positive Trends

Xconomist of the Week: Evan Snyder'stem Cell Reality Check

Good for Some, Good for All

Nokia Joins X Prize in $2.25M Wireless Health 'sensing Challenge

SD Life Sciences Roundup: Takeda Consolidates, Startups Raise Cash

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)